verapamil has been researched along with Hyperlipoproteinemia Type II in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buja, LM | 2 |
| Clubb, FJ | 1 |
| Bilheimer, DW | 2 |
| Willerson, JT | 2 |
| Dalessandri, KM | 1 |
| Lantz, BM | 1 |
| Tsukamoto, H | 1 |
| Link, DP | 1 |
| Brock, J | 1 |
| Tilton, GD | 1 |
| Apprill, P | 1 |
| Ashton, J | 1 |
| McNatt, J | 1 |
| Kita, T | 1 |
1 review available for verapamil and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit.
Topics: Animals; Cytoplasm; Disease Models, Animal; Dogs; Humans; Hyperlipidemia, Familial Combined; Hyperli | 1990 |
2 other studies available for verapamil and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Superior mesenteric artery vasoactivity in hyperlipidemic Watanabe rabbits versus normal lipidemic New Zealand controls.
Topics: Animals; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Ergonovine; Hyperlipoproteinemia Type | 1989 |
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Disease Models, Animal; Female; Hyperlipidemias | 1985 |